Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile.
Sharonova, T., Zhmurov, P., Kalinin, S., Nocentini, A., Angeli, A., Ferraroni, M., Korsakov, M., Supuran, C.T., Krasavin, M.(2022) J Enzyme Inhib Med Chem 37: 857-865
- PubMed: 35296197 
- DOI: https://doi.org/10.1080/14756366.2022.2051023
- Primary Citation of Related Structures:  
7QSI - PubMed Abstract: 
A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms h CA IX and XII was co-crystalized with h CA II showing significant potential for fragment periphery evolution via fragment growth and linking. These opportunities will be identified in the future via the screening of this fragment structure for co-operative carbonic anhydrase binding with other structurally diverse fragments.[Figure: see text].
Organizational Affiliation: 
Institute of Chemistry, Saint Petersburg State University, Saint Petersburg, Russia.